Abstract
Cisplatin a platinum-containing co-ordination complex, is an effective antineoplastic agent used in the treatment of a variety of human malignancies including ovarian, testicular and small cell lung tumours . The clinical use of cisplatin (CP) is limited chiefly by dose-relatedcumulative nephrotoxicity which is characterised by necrosis of the S3 segment of the proximal tubule. While CP is known to accumulate in the kidney (1) , the mechanism of renal cellular accumulation is unclear although it has been suggested (2) that the drug may interact with the organic transport system in the kidney. The pars recta is notably a major site of active transport which is further support for this theory.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Litterst, C.L. , 1981, Alterations in the toxicity of cisdichlorodiammine platinum II and in tissue localization of platinum as a function of NaC1 concentration in the vehicle of administration. Toxicol . Appl. Pharmacol., 61 : 99–108.
Safirstein, R. , Miller, P. and Guttenplan, J.B., 1984, Uptake and metabolism of cisplatin by rat kidney. Kidney Int ., 25 :753–758.
Hayes, D.M., Cvitkovic, E., Golbey, R. B., Scheiner, E., Helson, L., Krakoff, I.H., 1977, High dose cisplatinum diammine dichloride. Cancer, 39 :1372 .
Borch, R.F. , Pleasants, M.E. , 1979, Inhibition of nephrotoxicity by diethyldithiocarbamate rescue in a rat model. Proc. Natl. Acad. Sci . USA., 76:12: 6611–6614.
Kempf, S.R., Ivankovic, S., Wiessler, M., Schmahl, D., 1985, Effective prevention of the nephrotoxicity of cisplatin (CDDP) by administration of sodium 2-mercaptoethane-sulfonate (MESNA) in rats. Br. J. Cancer., 52: 937–939 .
Ward, J.M. , Crabin, M.E. , Berlin, E. , Young, D.M. , 1977, Prevention of renal failure in rats receiving cisdiamminedichloroplatinum (II) by administration of furosemide. Cancer Res., 37: 1238–1240.
Rabito, C.A. , 1986, Occluding junctions in a renal cell line (LLCPK1) with characteristics of proximal tubular cells. , Am. J. Physiol. 250:F734–F743.
De Conti, R.C., Toftness, B.R., Lange, R.C., Creasey, W.A., 1973, Clinical and pharmacological studies with cisdiamminedichloroplatinum (II). Cancer Res ., 33: 1310–1315.
Ormond, T. , McGuinness, S. , Pratt, I . , Ryan, M.P. , McAuliffe, C.A. , Sharma, H.L. , Tinker, N.D. , The effecto of amiloride on cisplatin induced nephrotoxicity and the renal uptake of ( mPt) cisplatin in male Wistar rats (this volume) .
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer Science+Business Media New York
About this chapter
Cite this chapter
Casey, B. et al. (1989). Uptake of Cisplatin (195mPt) Into LLCPK1 Cells in the Presence of Diethyldithiocarbamate (DDTC) , Mercaptoethanesulphate (MESNA) and Amiloride. In: Bach, P.H., Lock, E.A. (eds) Nephrotoxicity. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-2040-2_53
Download citation
DOI: https://doi.org/10.1007/978-1-4757-2040-2_53
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-2042-6
Online ISBN: 978-1-4757-2040-2
eBook Packages: Springer Book Archive